Stock Ratings / Health Care / IMCC / earnings

AKAN (46) NAII (31) BON (42) MTEX (45) ⌘ Pro Terminal →

IM Cannabis Corp. (IMCC) Next Earnings Date & Expected ±12.5% Move

$0.91 +3.53% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.91

IM Cannabis Corp. (IMCC) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $1.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on IMCC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is IMCC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, IM Cannabis Corp. (NASDAQ: IMCC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $0.91 (+3.53% 1D, market cap $1.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IMCC ranks #366 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does IMCC compare to AKAN and NAII in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), IMCC carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, AKAN (Akanda Corp.) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $2.6M) and NAII (Natural Alternatives International Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -10.8%, cap $6.9M). Among the 5-stock peer group, IMCC leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for IMCC?

▼

For IM Cannabis Corp. (IMCC), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #366 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.91 (+0.45%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-5.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IMCC)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (47/100 Composite)

🔍 WHY IMCC SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL Trailing 12 Months: 0% FCF Margin ($41.8K FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$1.46+2.7% Next Q

Q2 (-2Q)

Grade C-$1.50-42% Next Q

Q3 (-1Q)

Grade C-$0.87+4.6% Next Q

Current

Grade D$0.91-5.9% Hist 90D α

Trajectory: C (55) → D (47)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a IMCC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While IMCC currently carries a cautious 47/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.07) and Max Pain ($0.96) forces dealer call-delta covering toward $65.52.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IMCC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “IMCC Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 47%NO 53%Trade / Inspect Odds →

NEXT EST. WINDOW: Upcoming Quarter (~28 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.11 Expected Swing

MODEL EARNINGS SETUP GAUGE

IMCC Quantitative Pre-Earnings Setup: 47/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (47/100)Model Risk Weight (53/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring IMCC)

✓Walkthrough of IMCC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

IMCC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -89.36%🛡️ HOLDING TREND SUPPORT

2026-11-02O $0.88H $0.91L $0.88C $0.91VOL 23.5K

RES: $8.23SUP: $0.23SMA50: $2.07SMA200: $10.96

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IMCC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 IMCC Butterfly Map → + Track IMCC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IMCC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IMCC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for IMCC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IMCC)

Health Care Rank #366 of 1016 ⚔️ AKAN vs IMCC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (IMCC vs. AKAN, NAII, BON, MTEX)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, IM Cannabis Corp. (IMCC) ranks #366 by composite RQD confidence (47/100, grade D) and #1009 by equity capitalization ($1.5M). Within this direct 5-issuer industry benchmark cohort, IMCC leads on earnings valuation at N/A trailing P/E, while NAII leads on capital efficiency and profitability with -10.8% ROIC and 7.2% gross margin. IMCC currently leads its immediate peer cohort in composite quantitative strength at 47/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
IMCC ACTIVE IM Cannabis Corp.	D	47/100	—	—	—	+3.53%	$1.5M	Benchmark Subject
AKAN Akanda Corp.	D	46/100	—	—	—	+2.80%	$2.6M	/akan-vs-imcc →
NAII Natural Alternatives International Inc.	E	31/100	—	7.2%	-10.8%	-4.31%	$6.9M	/naii-vs-imcc →
BON Bon Natural Life Limited (Class A)	D-	42/100	—	20.8%	—	-0.01%	$9.2M	/bon-vs-imcc →
MTEX Mannatech Incorporated	D	45/100	—	74.9%	-35.0%	-2.23%	$16.1M	/mtex-vs-imcc →

2. IMCC Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

IM Cannabis Corp. (IMCC) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $1.5M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. IMCC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IMCC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does IMCC compare to AKAN and NAII in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for IMCC?

Where is IMCC trading relative to its 50-day, 200-day, and 52-week technical levels?

IMCC last traded at $0.91 (+3.53% on volume of 23,467 shares), positioning the stock -56.04% below its 50-day simple moving average ($2.07) and -91.70% below its 200-day simple moving average ($10.96). Across its 52-week range of $0.76 to $62.40, IMCC sits at the 0.2% percentile with a 14-day RSI of 35.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.02).

IMCC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is IMCC's next earnings date?

Based on SEC filing cadence, IM Cannabis Corp. (IMCC)'s next quarterly reporting window is estimated around Upcoming Quarter.

How much is IMCC stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for IMCC, spanning a range between $1 and $1.02.

Direct Sub-Reports: IMCC RQD Cockpit IMCC 12M Forecast IMCC Earnings & Move IMCC Dividends & DRIP IMCC Insiders & 13F IMCC Whale Options IMCC Profit Sankey IMCC News & Why